Setting 
My Cart
Toggle Nav
Close
  • Menu
  • Setting

Signaling Pathways

Signal transduction pathways constitute a precisely regulated network through which cells perceive external stimuli and initiate intracellular responses. Core research in this field focuses on the mechanisms of molecular signal transmission and regulation within cells and typically encompasses three fundamental stages: signal initiation, signal propagation through cascades, and downstream effector responses. Key molecules—including proteins, nucleic acids, and small molecules—interact with high specificity and are subject to tight regulation (e.g., protein phosphorylation, molecular activation/inhibition). These processes underpin the full spectrum of cellular activities, including proliferation, differentiation, metabolism, apoptosis, and immune responses. While accurate regulation of these pathways is essential for maintaining organismal homeostasis, their dysregulation is a major driver of the onset and progression of diseases such as cancer, neurodegenerative disorders, and autoimmune diseases.


APExBIO is strongly committed to advancing life science research by providing a comprehensive portfolio of small-molecule tools designed to support the elucidation of signaling mechanisms and the identification of key regulatory targets—critical steps for deciphering disease etiology and developing innovative therapies. Our offerings span all major signal transduction pathways, including classical pathways (e.g., PI3K/Akt, MAPK, NF-κB), emerging modalities (e.g., ferroptosis, cuproptosis, pyroptosis), and research on pathway crosstalk. With tens of thousands of products—including inhibitors, activators, and modulators—we robustly support research in oncology, immunology, neuroscience, epigenetics, and other key fields.


Every APExBIO product undergoes rigorous functional validation and purity testing, ensuring suitability for diverse research applications such as pathway mechanism studies, target identification and validation, drug activity evaluation, cell-based assays, and animal model development. We complement our high-quality tools with comprehensive support: each product is supplied with detailed chemical property reports, biological activity data, standardized usage guidelines, and extensive literature citations in high-impact journals. In addition, we provide end-to-end assistance—from product selection and experimental protocol optimization to technical troubleshooting—enabling researchers to rely on tool quality, focus on core scientific questions, and accelerate progress in signal transduction research and translational medicine.

Items 10511-10520 of 11976

Page
per page
  1. Prochloraz
    B8573 Prochloraz
    Summary: An imidazole compound with antifungal and hormone receptor-modulating activities.
      ≥103.8 mg/mL
  2. TCPOBOP
    B8576 TCPOBOP
    Summary: A specific CAR agonist that promotes hepatocyte proliferation and liver regeneration.
      ≥9.04 mg/mL
  3. GSK872
    B8589 GSK872
    Summary: Selectively inhibits RIPK3 kinase activity, blocking the necroptosis pathway.
      ≥36.1 mg/mL
      insoluble in H2O
  4. L-Methionine-DL-sulfoximine
    B8591 L-Methionine-DL-sulfoximine
    Summary: An irreversible, specific inhibitor of glutamine synthetase, affecting astrocyte metabolism.
      insoluble in DMSO; insoluble in EtOH; ≥2.6 mg/mL
  5. Lipofermata
    B8594 Lipofermata
    Summary: A fatty acid transport protein 2 inhibitor with zinc-dependent antibacterial activity.
      ≥39.1 mg/mL
  6. Thiamine pyrophosphate
    B8600 Thiamine pyrophosphate
    Summary: A key coenzyme involved in oxidative phosphorylation and the pentose phosphate metabolic pathway.
      insoluble in DMSO; insoluble in EtOH; ≥50.1 mg/mL
  7. pamoic acid
    B8621 pamoic acid
    Summary: A GPR35 agonist for neurodegenerative disease and inflammation research.
      insoluble in EtOH; insoluble in H2O; ≥10.68 mg/mL
  8. Vitamin K1
    B8631 Vitamin K1
    Summary: A fat-soluble vitamin used to treat coagulation disorders caused by coagulation factor deficiency.
  9. L-Cycloserine
    B8632 L-Cycloserine
    Summary: An orally available dual inhibitor of GABA-t and Mycobacterium tuberculosis branched-chain aminotransferase.
      insoluble in EtOH; ≥42.9 mg/mL
  10. Ethyl (R)-3-hydroxybutyrate
    B8639 Ethyl (R)-3-hydroxybutyrate
    Summary: A β-hydroxy ester pharmaceutical intermediate and enzyme-catalyzed substrate with a chiral structure.
      ≥51.5 mg/mL

Items 10511-10520 of 11976

Page
per page